Clinical Trial Update: Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety, tolerability, and efficacy of UCB7665 in adults with moderate to severe Myasthenia Gravis has completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• UCB7665

Snippet

Sponsor: UCB Biopharma S.P.R.L. | Conditions: Myasthenia Gravis | Phase 2 | Status: COMPLETED | Results posted: 2021-08-03